Trial Profile
A Pharmacokinetic and Pharmacodynamic Assessment of Prasugrel in Healthy Adults and Adults With Sickle Cell Disease.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Sickle cell anaemia; Thrombosis
- Focus Pharmacokinetics
- 15 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Jan 2011 Planned End Date changed from 1 Oct 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.